EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mitochondrial succinate transport is required for cardiac ischaemia/reperfusion injury

Laura Pala, María Torres-López, Stuart T Caldwell, Joyce Valadares, Emily M Smith, Katherine L Hammond, Olga Sauchanka, Jiro Abe, Thomas Krieg iD, Richard C Hartley, Michael P Murphy, Hiran A Prag iD

Cardiovascular Research · 28.04.2026 · 122 (6) · 734-747

DOI: 10.1093/cvr/cvag031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 28.01.2026. Verfasst von Laura Pala und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, University of Glasgow, Glasgow G12 8QQ, UK. Hauptthemen laut MEDLINE: Myocardial Reperfusion Injury, Mitochondria, Heart, Myocytes, Cardiac, Dicarboxylic Acid Transporters. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Medical Research Council, Wellcome Trust Investigator.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Succinate accumulates significantly during myocardial ischaemia, and its rapid oxidation upon reperfusion is a critical driver of ischaemia/reperfusion (I/R) injury. The transport of succinate across the mitochondrial inner membrane, particularly by the dicarboxylate carrier (DIC; SLC25A10), is hypothesized to play a crucial role in mediating these pathological succinate dynamics. However, tools to test this hypothesis by modulating mitochondrial succinate transport in biological systems are lacking. Methods and results C57BL/6J mice, isolated Wistar Rat heart mitochondria, bovine heart mitochondrial membranes, C2C12 mouse myoblasts, and primary adult mouse cardiomyocytes were used as in vitro and in vivo models. Butylmalonate prodrugs were synthesized and tested. Isolated mitochondria were used to assess succinate-dependent respiration and reactive oxygen species (ROS) production. Cells were treated with succinate dehydrogenase (SDH) inhibitors or exposed to anoxia and butylmalonate esters. Mouse hearts were subjected to in vivo left anterior descending coronary artery ligation. Succinate and butylmalonate levels were measured by targeted liquid chromatography-tandem mass spectrometry, and infarct size by TTC (23,5-triphenyl-2H-tetrazolium chloride) staining. Knockdown of DIC, but not of the oxoglutarate carrier OGC, in C2C12 cells prevented succinate accumulation by SDH inhibition and anoxia. The only extant DIC inhibitor butylmalonate, is limited by poor cell permeability. We synthesized diacetoxymethyl butylmalonate (DAB), which efficiently delivers butylmalonate intramitochondrially in isolated heart mitochondria and cells. DAB inhibited succinate-dependent respiration and ROS production. DAB prevented succinate accumulation in cells treated with SDH inhibitors. DAB delivered butylmalonate to cardiac mitochondria when administered to mice in vivo and reduced infarct size by perturbing mitochondrial succinate transport.

Conclusion

The DIC is a key node in the cellular distribution of succinate, controlling its transport between mitochondria and the cytosol. These findings highlight the potential of DIC as a promising therapeutic target for conditions where succinate elevation contributes to pathogenesis, such as cardiac I/R injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myocardial Reperfusion InjuryMitochondria, HeartMyocytes, CardiacDicarboxylic Acid TransportersSuccinic AcidMyocardial InfarctionAnimalsMice, Inbred C57BLMaleRats, WistarMalonatesReactive Oxygen SpeciesDisease Models, AnimalProdrugsSuccinate DehydrogenaseRatsCell LineMiceMitochondrial Membrane Transport ProteinsBiological TransportMembrane Transport Proteins

Stichwörter der Autor:innen

ButylmalonateIschaemia/reperfusion injuryMitochondrial dicarboxylate carrierMitochondrial transportMyocardial infarctionSLC25A10Succinate

Substanzen

Dicarboxylic Acid TransportersSuccinic AcidMalonatesReactive Oxygen SpeciesProdrugsSuccinate DehydrogenaseMitochondrial Membrane Transport Proteinsoxoglutarate translocatorMembrane Transport Proteins

Autor:innen und Institutionen

  • School of Chemistry, University of Glasgow, Glasgow G12 8QQ, UK.
  • Institute of Biomedicine of Seville (IBiS), Hospital 'Universitario Virgen del Rocío'/CSIC/University of Seville, Seville 41013, Spain.
  • Department of Medical Physiology and Biophysics, School of Medicine, University of Seville, Seville 41009, Spain.
  • MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge CB2 0XY, UK.
  • Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.

ORCID-Profile: Thomas Krieg, Hiran A Prag

Förderung

  • British Heart Foundation
  • Medical Research Council
  • Wellcome Trust Investigator
  • University of Glasgow studentship
  • Royal Society Research

Zitieren

APA

Pala, L., Torres-López, M., Caldwell, S. T., Valadares, J., Smith, E. M., Hammond, K. L., Sauchanka, O., Abe, J., Krieg, T., Hartley, R. C., Murphy, M. P., & Prag, H. A. (2026). Mitochondrial succinate transport is required for cardiac ischaemia/reperfusion injury. Cardiovascular Research, 122(6), 734-747. https://doi.org/10.1093/cvr/cvag031

Vancouver

Pala L, Torres-López M, Caldwell ST, Valadares J, Smith EM, Hammond KL, et al. Mitochondrial succinate transport is required for cardiac ischaemia/reperfusion injury. Cardiovascular Research. 2026;122(6):734-747. doi:10.1093/cvr/cvag031

BibTeX
@article{Pala2026,
  author = {Pala, Laura and Torres-López, María and Caldwell, Stuart T and Valadares, Joyce and Smith, Emily M and Hammond, Katherine L and Sauchanka, Olga and Abe, Jiro and Krieg, Thomas and Hartley, Richard C and Murphy, Michael P and Prag, Hiran A},
  title = {Mitochondrial succinate transport is required for cardiac ischaemia/reperfusion injury},
  journal = {Cardiovascular Research},
  year = {2026},
  volume = {122},
  number = {6},
  pages = {734--747},
  doi = {10.1093/cvr/cvag031}
}
Kostenlos starten →